FTC and DOJ lay out new rules for merger review to reflect a digital economy

[ad_1] The Federal Trade Commission and Department of Justice said Wednesday that their new focus when evaluating mergers will include the impact a deal will have on competition for workers along with how a series of acquisitions, rather than one-offs, could result in harmful effects on the market. The new guidelines, currently in draft form, … Read more

FTC says it will appeal to block Microsoft-Activision deal

[ad_1] Satya Nadella, CEO, Microsoft, at the Allen & Company Sun Valley Conference on July 11, 2023 in Sun Valley, Idaho. David A. Grogan | CNBC The Federal Trade Commission is not giving up on its bid to prevent Microsoft from closing its $68.7 billion acquisition of game publisher Activision Blizzard. On Wednesday, the agency … Read more

FTC to file injunction seeking to block Microsoft’s acquisition of Activision Blizzard

[ad_1] FTC Chairwoman Lina Khan testifies during the House Energy and Commerce Subcommittee on Innovation, Data, and Commerce hearing on the “FY2024 Federal Trade Commission Budget,” in Rayburn Building on Tuesday, April 18, 2023. Tom Williams | Cq-roll Call, Inc. | Getty Images The Federal Trade Commission is set to file for an injunction seeking … Read more

German authorities looking into possible data protection violations by Tesla, newspaper reports

[ad_1] The Tesla factory in Tilburg, Netherlands. Jasper Juinen | Bloomberg | Getty Images German authorities have serious indications of possible data protection violations by Tesla, Handelsblatt newspaper reported on Thursday, citing the data protection office in the state where the carmaker has its European gigafactory. Handelsblatt’s report said the U.S. electric car manufacturer has failed to adequately protect data from customers, employees and business partners, citing 100 gigabytes of confidential data leaked to … Read more

Pfizer CEO signs open letter calling for reversal of Texas abortion pill ruling

[ad_1] Pfizer‘s CEO signed on to an open letter calling for the reversal of a federal judge’s decision to suspend the Food and Drug Administration’s approval of the abortion pill mifepristone. Albert Bourla was among the more than 200 pharmaceutical company executives who signed the letter after U.S. Judge Matthew Kacsmaryk’s controversial ruling Friday. “We … Read more